PMID: 2422382Jan 1, 1986Paper

Modification of single cardiac Na+ channels by DPI 201-106

The Journal of Membrane Biology
M KohlhardtJ W Herzig

Abstract

In inside-out patches from cultured neonatal rat heart cells, single Na+ channel currents were analyzed under the influence of the cardiotonic compound DPI 201-106 (DPI), a putative novel channel modifier. In absence of DPI, normal cardiac single Na+ channels studied at -30 mV have one open state which is rapidly left with a rate constant of 826.5 sec -1 at 20 degrees C during sustained depolarization. Reconstructed macroscopic currents relax completely with 7 to 10 msec. The current decay fits a single exponential. A considerable percentage of openings may occur during relaxation of the macroscopic current. In patches treated with 3 X 10(-6) m DPI in the pipette solution, stepping to -30 mV results in drastically prolonged and usually repetitive openings. This channel activity mostly persists over the whole depolarization (usually 160 msec in duration) but is abruptly terminated on clamping back the patch to the holding potential. Besides these modified events, apparently normal openings occur. The open time distribution of DPI-treated Na+ channels is the sum of two exponentials characterized by time constants of 0.85 msec (which is close to the time constant found in the control patches, 1.21 msec) and 12 msec. Moreover, DPI-...Continue Reading

References

Mar 15, 1979·Nature·J J Colatsky, R W Tsien
Mar 15, 1979·Nature·K S LeeA M Brown
Mar 1, 1978·The Journal of General Physiology·G S OxfordT Narahashi
Jan 1, 1975·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·E M Vaughan Williams
Feb 10, 1971·Nature: New Biology·E Rojas, C Armstrong
Nov 1, 1966·Experimental Cell Research·G E Mark, F F Strasser
Oct 1, 1984·The Journal of General Physiology·R Horn, C A Vandenberg
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Mar 1, 1982·The Journal of General Physiology·J Patlak, R Horn
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·L Y HuangG Ehrenstein
Nov 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·F N Quandt, T Narahashi
Jul 1, 1983·The Journal of Physiology·A B CachelinH Reuter
Sep 1, 1983·Pflügers Archiv : European journal of physiology·A CavaliéW Trautwein
Dec 1, 1983·Circulation Research·A O GrantH C Strauss
Dec 1, 1983·Pflügers Archiv : European journal of physiology·K NagyD Hof
Jan 1, 1983·Cold Spring Harbor Symposia on Quantitative Biology·H ReuterS Kokubun
May 1, 1984·The Journal of General Physiology·H D Lux, A M Brown
Sep 1, 1981·The Journal of Physiology·A M BrownT Powell
Apr 1, 1980·The Journal of General Physiology·L EbiharaE A Johnson
Apr 1, 1952·The Journal of Physiology·A L HODGKIN, A F HUXLEY

❮ Previous
Next ❯

Citations

Dec 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·P K SieglG J Kaczorowski
Jan 1, 1991·European Biophysics Journal : EBJ·I BenzM Kohlhardt
Sep 1, 1987·Pflügers Archiv : European journal of physiology·C O Malécot, W Trautwein
Jan 1, 1989·Pflügers Archiv : European journal of physiology·B NiliusE Carmeliet
Nov 1, 1989·The Journal of Membrane Biology·M KohlhardtU Fröbe
Jan 1, 1991·The Journal of Membrane Biology·J W Herzig, M Kohlhardt
Jun 1, 1991·The Journal of Membrane Biology·I Benz, M Kohlhardt
May 1, 1991·The Journal of Membrane Biology·M Kohlhardt
Dec 1, 1991·Computers and Biomedical Research, an International Journal·J L HurwitzA O Grant
Oct 26, 1988·European Journal of Pharmacology·M Kohlhardt, H Fichtner
Jun 8, 1989·European Journal of Pharmacology·J L GerardJ F Giudicelli
Aug 10, 1990·European Journal of Pharmacology·J L GérardJ F Giudicelli
Apr 10, 1991·European Journal of Pharmacology·E Carmeliet, J Tytgat
Dec 1, 1991·Trends in Cardiovascular Medicine·A O Grant
Jul 1, 1992·Trends in Cardiovascular Medicine·S A Cohen, R L Barchi
Sep 1, 1994·Journal of Pharmacological and Toxicological Methods·L VittoneH Cingolani
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G RomeyM Lazdunski
Oct 1, 1988·The Journal of General Physiology·J B Patlak
Mar 1, 1990·The Journal of General Physiology·B E ScanleyH A Fozzard
Nov 1, 1990·Pacing and Clinical Electrophysiology : PACE·A O Grant
Jun 27, 2003·Journal of Cardiovascular Pharmacology·Volker KühlkampLudger Seipel
Nov 1, 1990·International Journal of Cardiology·M E DavisR K Walesby
May 1, 1987·British Journal of Pharmacology·A J KaumannD A Russell
Oct 1, 1986·British Journal of Pharmacology·G Scholtysik, F M Williams
Aug 18, 2001·Journal of Cardiovascular Pharmacology and Therapeutics·M MevissenG Scholtysik
Feb 1, 1992·Circulation Research·N el-SherifD A Hanck
Oct 22, 1987·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·M KohlhardtJ W Herzig
Sep 27, 2005·Physiological Reviews·Werner Ulbricht
Jan 1, 1988·European Biophysics Journal : EBJ·M KohlhardtU Fröbe
Apr 1, 1994·Cardiovascular Drugs and Therapy·W ZierhutR P Hof

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.